Literature DB >> 8464427

Differential expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC in hematopoietic cells: analysis of transcripts.

D L Cassel1, M A Keller, S Surrey, E Schwartz, A D Schreiber, E F Rappaport, S E McKenzie.   

Abstract

Fc gamma receptors (Fc gamma R) are glycoproteins that function in the immune response through their ability to bind the Fc portion of immunoglobulin G. Of the three human Fc gamma R classes, Fc gamma RII is most widely distributed among hematopoietic cells and is the only Fc gamma R class present on platelets and megakaryocytes. There are three different genes coding for Fc gamma RII: Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC. Alternative splicing of at least two of these genes results in the production of multiple transcripts. Combining Northern blot analysis with reverse transcription-PCR, we analyzed steady state levels of Fc gamma RII mRNA in the megakaryocytic, myeloid and lymphoid lineages. We determined that megakaryocytic cells predominantly contain Fc gamma RIIA mRNA; Fc gamma RIIA transcripts with and without the transmembrane exon (Fc gamma RIIa1 and Fc gamma RIIa2, respectively) are present in comparable amounts. In contrast, B lymphocytes do not express Fc gamma RIIA mRNAs, but do contain both Fc gamma RIIB transcripts, Fc gamma RIIb1 and Fc gamma RIIb2, as well as the Fc gamma RIIC transcript, Fc gamma RIIc. Myelomonocytic cells contain mRNAs from all three Fc gamma RII genes, predominantly the Fc gamma RIIa1 transcript, both Fc gamma RIIb1 and Fc gamma RIIb2 transcripts and Fc gamma RIIc. Lineage-specific expression of the Fc gamma RII genes implies both differential regulation of expression and differential function in diverse cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464427     DOI: 10.1016/0161-5890(93)90113-p

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

Review 1.  Functions of the Fc receptors for immunoglobulin G.

Authors:  B K Flesch; J Neppert
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Human platelet FcγRIIA and phagocytes in immune-complex clearance.

Authors:  Zhen-Yu Huang; Paul Chien; Zena K Indik; Alan D Schreiber
Journal:  Mol Immunol       Date:  2010-12-17       Impact factor: 4.407

3.  The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.

Authors:  M B Callanan; P Le Baccon; P Mossuz; S Duley; C Bastard; R Hamoudi; M J Dyer; G Klobeck; R Rimokh; J J Sotto; D Leroux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Lineage-specific alternative splicing of the human Fc gamma RIIA transmembrane exon requires sequences near the 3' splice site.

Authors:  M A Keller; S E McKenzie; D L Cassel; E F Rappaport; E Schwartz; S Surrey
Journal:  Gene Expr       Date:  1995

5.  Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism.

Authors:  A F Reilly; C F Norris; S Surrey; F J Bruchak; E F Rappaport; E Schwartz; S E McKenzie
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

6.  Abrogation of the Fc gamma receptor IIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides.

Authors:  M Matsuda; J G Park; D C Wang; S Hunter; P Chien; A D Schreiber
Journal:  Mol Biol Cell       Date:  1996-07       Impact factor: 4.138

7.  In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation.

Authors:  N Bewarder; V Weinrich; P Budde; D Hartmann; H Flaswinkel; M Reth; J Frey
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

8.  Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody.

Authors:  Lubna Abuqayyas; Xiaoyan Zhang; Joseph P Balthasar
Journal:  Int J Pharm       Date:  2013-01-28       Impact factor: 5.875

9.  FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

Authors:  Shuying S Li; Peter B Gilbert; Georgia D Tomaras; Gustavo Kijak; Guido Ferrari; Rasmi Thomas; Chul-Woo Pyo; Susan Zolla-Pazner; David Montefiori; Hua-Xin Liao; Gary Nabel; Abraham Pinter; David T Evans; Raphael Gottardo; James Y Dai; Holly Janes; Daryl Morris; Youyi Fong; Paul T Edlefsen; Fusheng Li; Nicole Frahm; Michael D Alpert; Heather Prentice; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Merlin L Robb; Robert J O'Connell; Barton F Haynes; Nelson L Michael; Jerome H Kim; M Juliana McElrath; Daniel E Geraghty
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

10.  Bacillus anthracis peptidoglycan activates human platelets through FcγRII and complement.

Authors:  Dawei Sun; Narcis I Popescu; Brent Raisley; Ravi S Keshari; George L Dale; Florea Lupu; K Mark Coggeshall
Journal:  Blood       Date:  2013-06-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.